SUSAN CANN: Open Payments
NPI 1336277359 · BRIGHTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$219 in 9 payments from 9 companies in 2025. Trend: 2023 $384 · 2024 $79 · 2025 $219
Food & beverage: $219
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 1 | $39 |
| Alvogen Inc | 1 | $25 |
| Abbott Laboratories | 1 | $25 |
| Tandem Diabetes Care, Inc. | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Amgen Inc. | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| Novo Nordisk Inc | 1 | $23 |
| BETA BIONICS, INC. | 1 | $13 |
Products named: Korlym, TERIPARATIDE, FREESTYLE LIBRE 3, t:slim X2 Insulin Pump with Control-IQ, RECORLEV, EVENITY, JARDIANCE, iLet Bionic Pancreas.
Industry payments across MA — which companies pay providers there.
